Loblaw Stock Dips 5% as Q1 Revenue Miss Overshadows Profit Growth
Earnings James Calloway

Loblaw Stock Dips 5% as Q1 Revenue Miss Overshadows Profit Growth

Loblaw reported Q1 revenue of C$14.48B, missing forecasts, sending shares down 5%. Net earnings rose to C$594M, and the company raised its dividend by 10% while approving a new buyback.

L
Celsius Stock Tests Lows as PepsiCo Partnership Faces Earnings Scrutiny
Earnings James Calloway

Celsius Stock Tests Lows as PepsiCo Partnership Faces Earnings Scrutiny

Celsius Holdings shares trade near a 52-week low before Q1 earnings, with investors focused on PepsiCo partnership execution and portfolio expansion results.

CELH PEP MNST KDP COST
Beyond Meat Tops $1 Ahead of Q1 Results, Nasdaq Compliance in Focus
Earnings James Calloway

Beyond Meat Tops $1 Ahead of Q1 Results, Nasdaq Compliance in Focus

Beyond Meat shares reclaimed the $1 mark ahead of first-quarter earnings, but Nasdaq compliance pressure remains as the company faces a deadline to boost its stock price.

BYND
Compass Shares Surge 26% on Q1 Profit and Upbeat Q2 Forecast After Anywhere Deal
Earnings James Calloway

Compass Shares Surge 26% on Q1 Profit and Upbeat Q2 Forecast After Anywhere Deal

Compass Inc. shares surged 26% after reporting a first-quarter profit and issuing a strong second-quarter revenue forecast, boosted by its Anywhere Real Estate acquisition.

COMP
Bayer's $2.45B Perfuse Buy Aims to Revitalize Eye Drug Pipeline
Markets Daniel Marsh

Bayer's $2.45B Perfuse Buy Aims to Revitalize Eye Drug Pipeline

Bayer acquires Perfuse Therapeutics for up to $2.45 billion to secure Phase II eye drug PER-001, aiming to bolster its ophthalmology unit as Eylea sales slip.

REGN RHHBY
NICE Ltd Shares Slump 23% on Weak Q2 Forecast Despite AI Growth
Earnings James Calloway

NICE Ltd Shares Slump 23% on Weak Q2 Forecast Despite AI Growth

NICE Ltd shares tumbled 22.9% to $96.35 after Q2 revenue guidance fell short of expectations, despite a Q1 earnings beat and strong AI recurring revenue growth of 66%.

NANO Nuclear Soars on Supermicro Pact for AI Data Center Power
Markets Daniel Marsh

NANO Nuclear Soars on Supermicro Pact for AI Data Center Power

NANO Nuclear Energy shares jumped 24.6% after announcing a non-binding MOU with Super Micro Computer to explore powering AI data centers with microreactors. No final contracts or reactor approvals have been secured yet.

NNE SMCI OKLO SMR
Ernexa Therapeutics Surges 60% on Promising Ovarian Cancer Preclinical Data
Markets Daniel Marsh

Ernexa Therapeutics Surges 60% on Promising Ovarian Cancer Preclinical Data

Ernexa Therapeutics shares jumped about 60% after the company announced its ERNA-101 cell therapy plus PD-1 blockade eliminated tumors and achieved 100% long-term survival in preclinical ovarian cancer models.

ERNA
Dell Surges on AI Server Demand, Texas Move Vote Looms
Technology Sarah Chen

Dell Surges on AI Server Demand, Texas Move Vote Looms

Dell shares surged 10% as AI server demand drives rally. Company seeks shareholder approval to move legal home to Texas at June 25 annual meeting.

DELL AMD SMCI HPE
D-Wave Stock Surges on London Conference Plans Ahead of Earnings
Technology Sarah Chen

D-Wave Stock Surges on London Conference Plans Ahead of Earnings

D-Wave Quantum (QBTS) shares jumped over 9% after setting June 18 for Qubits Europe 2026 in London, ahead of its May 12 earnings release. Analysts forecast a loss of 8 cents per share on $4.19M revenue.

QBTS IONQ RGTI
CDW Shares Tumble 19% as Hardware Shift Squeezes Margins Despite Sales Beat
Earnings James Calloway

CDW Shares Tumble 19% as Hardware Shift Squeezes Margins Despite Sales Beat

CDW shares plunged 19% after Q1 gross margin fell to 21% from 21.6%, even as revenue topped expectations at $5.68 billion. The shift toward lower-margin hardware sales weighed on earnings.

CDW
Joby Aviation Soars 18% on Q1 Revenue Beat, 2026 Air Taxi Plans
Earnings James Calloway

Joby Aviation Soars 18% on Q1 Revenue Beat, 2026 Air Taxi Plans

Joby Aviation shares jumped 18% after Q1 revenue exceeded expectations and the company reiterated its target for initial passenger flights in 2026, with $2.5 billion in cash to fund certification and factory projects.

JOBY ACHR